Bacillus Subtilis Class Ib Ribonucleotide Reductase: High Activity and Dynamic Subunit Interactions by Zhu, Xuling et al.
Bacillus subtilis Class Ib Ribonucleotide Reductase: High Activity and
Dynamic Subunit Interactions
Mackenzie J. Parker,† Xuling Zhu,†,# and JoAnne Stubbe*,†,‡
Departments of †Chemistry and ‡Biology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge,
Massachusetts 02139, United States
*S Supporting Information
ABSTRACT: The class Ib ribonucleotide reductase (RNR)
isolated from Bacillus subtilis was recently puriﬁed as a 1:1 ratio
of NrdE (α) and NrdF (β) subunits and determined to have a
dimanganic-tyrosyl radical (MnIII2-Y·) cofactor. The activity of
this RNR and the one reconstituted from recombinantly
expressed NrdE and reconstituted MnIII2-Y· NrdF using
dithiothreitol as the reductant, however, was low (160 nmol
min−1 mg−1). The apparent tight aﬃnity between the two
subunits, distinct from all class Ia RNRs, suggested that B.
subtilis RNR might be the protein that yields to the elusive X-
ray crystallographic characterization of an “active” RNR complex. We now report our eﬀorts to optimize the activity of B. subtilis
RNR by (1) isolation of NrdF with a homogeneous cofactor, and (2) identiﬁcation and puriﬁcation of the endogenous
reductant(s). Goal one was achieved using anion exchange chromatography to separate apo-/mismetalated-NrdFs from MnIII2-Y·
NrdF, yielding enzyme containing 4 Mn and 1 Y·/β2. Goal two was achieved by cloning, expressing, and purifying TrxA
(thioredoxin), YosR (a glutaredoxin-like thioredoxin), and TrxB (thioredoxin reductase). The success of both goals increased the
speciﬁc activity to ∼1250 nmol min−1 mg−1 using a 1:1 mixture of NrdE:MnIII2-Y· NrdF and either TrxA or YosR and TrxB. The
quaternary structures of NrdE, NrdF, and NrdE:NrdF (1:1) were characterized by size exclusion chromatography and analytical
ultracentrifugation. At physiological concentrations (∼1 μM), NrdE is a monomer (α) and MnIII2-Y· NrdF is a dimer (β2). A 1:1
mixture of NrdE:NrdF, however, is composed of a complex mixture of structures in contrast to expectations.
Ribonucleotide reductases (RNRs, Figure 1) catalyze theconversion of nucleoside 5′-diphosphates (NDPs) to
deoxynucleotides (dNDPs) and play an essential role in
supplying balanced dNTP pools for DNA replication and
repair.1 The RNRs have been classiﬁed based on the metallo-
cofactors used to generate a transient cysteine thiyl radial that is
essential for catalysis.2 The class I RNRs contain two subunits
(α and β) with subclassiﬁcation (Ia, Ib, and Ic, Figure 1) based
on the dimetallo-cofactor located in β. Class Ib RNRs, as with
class Ia enzymes, were long thought to use a diferric-tyrosyl
radical (FeIII2-Y·) cofactor because the cluster can self-assemble
and has catalytic activity.3−5 Recently however, the class Ib
RNRs have been isolated and characterized from their
endogenous sources (Corynebacterium ammoniagenes, Escher-
ichia coli, and Bacillus subtilis) in suﬃcient amounts to establish
that the cofactor is a dimanganic-tyrosyl radical (MnIII2-Y·).
6−9
While most prokaryotes have multiple RNRs, B. subtilis has a
single essential class Ib RNR found in the nrdI-nrdE-nrdF-ymaB
operon.10−12 The apparent tight binding of the subunits of the
B. subtilis RNR9 and the low reported speciﬁc activities of this
and other class Ib enzymes (Supporting Information, SI-Table
1), provided the impetus to maximize its catalytic activity for
future structural determination.
In all class I RNRs, α (designated NrdE for class Ib and
NrdA for class Ia, Figure 1) contains the active site for NDP
reduction and binding sites for allosteric eﬀectors that control
substrate speciﬁcity.1 The class Ia α contains a second allosteric
site in its N-terminal ATP cone domain that controls the
overall rate of nucleotide reduction and is absent in the class Ib
α subunits. The β subunit (NrdF for class Ib and NrdB for class
Ia) are all dimeric (β2) with the class Ia housing a Fe
III
2-Y·
cofactor (typically with 3.6 Fe/β2 and 1 Y·/β2) and the class Ib
housing a MnIII2-Y·, whose stoichiometry remains to be
optimized in all systems.2
Recent data suggest that in addition to allosteric eﬀectors,
quaternary structure(s) of the class I RNRs, including subunit
aﬃnity and its dependence on nucleotide binding, are all
important in regulating RNR activity.1 The subunit aﬃnity in
the E. coli and human class Ia RNRs have reported Kd’s of ∼0.2
μM in the presence of substrate (CDP)/eﬀector (ATP).13−15
While there is now a consensus that the active quaternary
structure of E. coli class Ia RNR is α2β2,
16−18 the eukaryotic Ia
structure is open to debate [(α2)n(β2)m (n = 1, 3 and m = 1,
3)].19−21 Recent studies have further revealed that the active
complexes of both the prokaryotic and eukaryotic RNRs are
dynamic.16,17,21,22 The quaternary structures of the class Ib
Received: August 4, 2013
Revised: November 22, 2013
Published: January 8, 2014
Article
pubs.acs.org/biochemistry
© 2014 American Chemical Society 766 dx.doi.org/10.1021/bi401056e | Biochemistry 2014, 53, 766−776
This is an open access article published under an ACS AuthorChoice License, which permits
copying and redistribution of the article or any adaptations for non-commercial purposes.
RNRs, especially with the MnIII2-Y· cofactor, have been much
less extensively studied and remain to be determined.3,23,24
Since the establishment that class Ib RNRs possess a MnIII2-
Y· cofactor, many eﬀorts have been made to isolate and
characterize these enzymes.6−9,23−25 With one exceptiona, the
reported activities of puriﬁed class Ib RNRs, whether
endogenously or recombinantly sourced, are substantially
lower (Supporting Information, SI-Table 1) than their class
Ia counterparts (5000−8000 nmol min−1 mg−1).26 Recently our
lab isolated the class Ib RNR from B. subtilis with NrdE and
NrdF copurifying in a 1:1 ratio through three chromatographic
steps in the absence of nucleotides and Mg2+, suggesting “tight”
subunit aﬃnity.9 However, while the RNR was 80% pure, its
catalytic activity was low (∼160 nmol min−1 mg−1). Eﬀorts to
reconstitute active RNR using recombinantly expressed NrdE
and reconstituted MnIII2-Y· NrdF also resulted in low catalytic
activity.9,27
In this paper, we report optimization of the catalytic activity
of the B. subtilis RNR by separation of active MeIII2-Y· loaded-
NrdF (Me = Fe or Mn) from the apo- and mismetalated forms
and that the active form has 1 Y·/β2 and 4 Mn/β2. We also
report the identiﬁcation, cloning, expression, and puriﬁcation of
candidate genes for the endogenous reductants for B. subtilis
RNR: TrxA and YosR, a thioredoxin and a glutaredoxin-like
thioredoxin, respectively, and TrxB, a thioredoxin reductase.
Activity assays with a 1:1 ratio of MnIII2-Y· NrdF:NrdE using
either TrxA or YosR with TrxB gave speciﬁc activities of ∼1250
nmol min−1 mg−1, 7-fold higher activity than the FeIII2-Y·
cofactor, and substantially higher than other class Ib RNRs
(Supporting Information, SI-Table 1). A comparison of the
ability of DTT versus the endogenous reductants to support
RNR activity with puriﬁed or unpuriﬁed MnIII2-Y· NrdF
revealed that the use of the endogenous reductants contributed
signiﬁcantly more to the activity enhancement relative to the
cluster loading of NrdF. Activity assays with CDP/ATP and
increasing concentrations of NrdE:NrdF maintained in a 1:1
ratio gave an apparent Km of 25 nM, 10-fold lower than the
apparent Kd for the Ia RNRs with the same substrate/eﬀector
pair.13,14 The quaternary structure of each subunit and a 1:1
mixture of NrdE:NrdF at physiological concentrations (1 μM)9
was examined by size exclusion chromatography (SEC) and
sedimentation velocity analytical ultracentrifugation (SV-AUC)
in the absence of nucleotides. These studies reveal that NrdE is
a monomer, MeIII2-Y· NrdF is a dimer, and the 1:1 mixture of
NrdE and NrdF is a mixture of subunits and higher molecular
weight species. These studies set the stage for determination of
nucleotide binding and how it eﬀects subunit interactions and
quaternary structure in a class Ib RNR.
■ MATERIALS AND METHODS
Materials. Chemical reagents were obtained from Sigma-
Aldrich at the highest purity available. Restriction enzymes, T4
DNA ligase, and isopropyl-β-D-1-thiogalactoside (IPTG) were
purchased from Promega (Madison, WI). All DNA sequencing
of cloned genes was carried out at the Massachusetts Institute
of Technology Biopolymers Laboratory. Ni-NTA Fast Flow
aﬃnity resin was from Qiagen. Complete EDTA-free protease
inhibitor tablets and calf alkaline phosphatase (20 μmol min−1
μL−1) were purchased from Roche Biochemicals (Indianapolis,
IN). Amicon Ultra-15 centrifugal ﬁlter devices were from
Millipore. N-Terminally His6-tagged NrdI and apo-NrdF were
expressed and puriﬁed as reported previously.9,27 Apo-NrdF
was reconstituted with MnIII2-Y· and Fe
III
2-Y· as previously
described.9,28
Cloning, Expression, and Puriﬁcation of N-Terminally
His6-tagged TrxA, TrxB, and YosR. The genes trxA, yosR,
and trxB were ampliﬁed by PCR using B. subtilis JH624
genomic DNA (a gift from A. Grossman in the Department of
Biology, Massachusetts Institute of Technology) as a template
and the primers listed in Supporting Information, SI-Table 2.
The ampliﬁed DNA fragments were digested with NdeI and
XhoI and ligated into pET14b (Novagen) using T4 DNA ligase
to create the vectors pXZtrxA, pXZtrxB, and pXZyosR.
TrxA and YosR were overproduced from pXZtrxA and
pXZyosR, respectively, transformed into BL21 (DE3) pLysS E.
coli cells (Invitrogen). Cells were grown in 1 L of ampicillin-
supplemented (Amp, 100 μg/mL) LB broth in 6 L Erlenmeyer
ﬂasks at 37 °C with 200 rpm shaking. At an OD600 of 0.8, IPTG
was added to a ﬁnal concentration of 0.2 mM and cultures were
incubated for an additional 2 h before harvest. TrxB was
overproduced from pXZtrxB transformed into BL21 (DE3)
Codon Plus RIL-X E. coli cells (Agilent Technologies)
following the same procedure with the exception that baﬄed
2.8 L Fernbach ﬂasks were used for culture growth and
incubation postinduction was extended to 3 h before harvest.
Typical yields were 2.4−3.0 g cell paste L−1 for all strains.
The puriﬁcation of all three proteins was the same through
the nickel aﬃnity step unless otherwise noted and was carried
out at 4 °C. Cell pellets were thawed on ice and resuspended to
0.2 g paste mL−1 in buﬀer A (50 mM sodium phosphate, 300
mM NaCl, 10 mM imidazole, 5% (w/v) glycerol, pH 7.6)
supplemented with protease inhibitors. Cells were lysed by
passage through a French pressure cell at 14 000 psi and the
debris was removed by centrifugation (35000g, 20 min).
Streptomycin sulfate solution was added to the stirring cell
extracts dropwise over 10 min to a ﬁnal concentration of 1%
(w/v). After an additional 15 min of stirring, precipitated
Figure 1. Ribonucleotide reduction catalyzed by class I RNRs. (A)
The class Ib RNRs are composed of NrdE (α) and NrdF (β) which are
proposed to form an α2β2 complex during substrate turnover (only
one α/β pair depicted). The stable dimaganic-Y· housed in β (1 Y·/β2)
oxidizes an essential Cys residue in the active site of α to a thiyl radical
through a long-range radical transfer process involving redox-active
amino acids in both subunits. Reduction of NDPs to dNDPs occurs
concomitant with oxidation of two Cys residues to a disulﬁde. The
disulﬁde is rereduced by a thioredoxin (TR) or NrdH (a glutaredoxin-
like thioredoxin), thioredoxin reductase (TRR), and NADPH. (B)
The dimetallo-cofactors of the class Ia and Ic β subunits.
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materials were removed by centrifugation (35000g, 20 min).
The streptomycin treatment was not used in the puriﬁcation of
TrxB as it caused precipitation of the desired protein. Clariﬁed
extracts were incubated with Ni-NTA resin equilibrated in
buﬀer A for 1 h (1 mL of resin per 2.5 g of cell paste) on a
rocker. The resin was then packed into a column and washed
with 20 column volumes (CVs) of buﬀer B (50 mM sodium
phosphate, 300 mM NaCl, 20 mM imidazole, 5% (w/v)
glycerol, pH 7.6) before eluting protein with buﬀer C (50 mM
sodium phosphate, 300 mM NaCl, 200 mM imidazole, 5% (w/
v) glycerol, pH 7.6). Protein-containing fractions were
identiﬁed using 15% SDS-PAGE gels and were then pooled
and desalted on a Sephadex G-25 column with buﬀer D (50
mM sodium phosphate, 5% (w/v) glycerol, pH 7.6).
TrxA was puriﬁed further with a Sephadex G-75 column (41
× 2.5 cm, 0.25 mL min−1) equilibrated with SEC buﬀer (50
mM sodium phosphate, 150 mM NaCl, pH 7.6). The fractions
containing TrxA, assessed by SDS-PAGE, were pooled and
desalted with an Amicon Ultra-15 YM-3 centrifugal ﬁlter (3000
MWCO). Typical yields were 11 ± 4 mg TrxA g−1 cell paste.
Purity was assessed by 15% SDS-PAGE (Supporting
Information, SI-Figure 1), and protein concentrations were
estimated by ε280 of 12 700 M
−1 cm−1 (DNASTAR Lasergene
8). The speciﬁc activity (SA) of the puriﬁed TrxA was ∼8−20
U/mg by the 5,5′-dithiobis-(2-nitrobenzoic acid) (DTNB)
assay.29,30
YosR and TrxB were further puriﬁed by anion exchange
chromatography on a BioCAD SPRINT FPLC system
(PerSeptive Biosystems). Protein was loaded onto a Poros
HQ/20 column (Applied Biosystems, 1.6 cm × 10 cm)
equilibrated in AEX buﬀer (25 mM Tris, 5% (v/v) glycerol, pH
7.6) supplemented with 100 mM NaCl. The column was
washed with 1 CV of equilibration buﬀer before development
with a 100 mL linear gradient from 100 to 700 mM NaCl in
AEX buﬀer. YosR eluted in the range of 350−450 mM NaCl
(ﬂow rate = 2 mL min−1) and TrxB in the range of 230−280
mM NaCl (ﬂow rate = 1 mL min−1). Fractions containing TrxB
were pooled by activity, exchanged to 50 mM NaPi, pH 7.6,
150 mM NaCl, and concentrated with an Amicon Ultra-15
YM30 centrifugal ﬁlter device (30000 MWCO). Fractions
containing YosR, as assessed by 15% SDS-PAGE, were pooled,
desalted, and concentrated with an Amicon Ultra-15 YM-3
centrifugal ﬁlter device. YosR was subjected to further
puriﬁcation using the SEC method described for TrxA. Typical
yields were 3 mg YosR g−1 cell paste and 0.4 mg TrxB g−1 cell
paste. Purity was assessed by 15% SDS-PAGE (Supporting
Information, SI-Figure 1). The concentration of YosR was
estimated by ε280 of 11 000 M
−1 cm−1 (DNASTAR Lasergene
8). The concentration of TrxB was estimated with the BCA
assay using BSA as a standard.31 The FAD content of TrxB was
determined as previously described.32 SAs of YosR and TrxB of
∼20−26 U/mg and 415 U/mg, respectively, were determined
using the DTNB assay.29,30 One unit is deﬁned as the amount
of enzyme catalyzing a ΔA412 of 1.0 min−1.29,30
Puriﬁcation of NrdE. NrdE was puriﬁed as previously
described except that buﬀer supplementation with NaCl and an
additional anion exchange chromatographic step were intro-
duced (see Supporting Information).9
Puriﬁcation of holo-MeIII2-Y· (Me = Fe or Mn)
Subsequent to Cofactor Assembly. EDTA (pH 7.6) to a
ﬁnal concentration of 5 mM was added to 1 mL of
reconstituted MeIII2-Y· NrdF (40 μM Mn-loaded protein or
300 μM Fe-loaded protein, ∼0.6 Y·/β2). Subsequent steps were
at 4 °C. Samples were mixed, clariﬁed by centrifugation
(20817g, 2 min), and loaded onto a MonoQ 10/100GL anion
exchange column (GE Healthcare, 10 × 1 cm) equilibrated
with 50 mM Tris, pH 7.6, 5% (w/v) glycerol and 100 mM
NaCl. The column was washed with 1.3 CVs of equilibration
buﬀer before elution with a 100 mL linear gradient from 100 to
350 mM NaCl in Tris buﬀer at a ﬂow rate of 1 mL min−1.
Apo-/mismetalated NrdF eluted at 250−280 mM NaCl (peak
1, Figure 2) and holo-protein at 280−310 mM (peak 2, Figure
2). Fractions (2 mL) containing protein were identiﬁed by A280,
and protein from each peak was pooled, exchanged into storage
buﬀer (50 mM HEPES, 5% (w/v) glycerol, pH 7.6), and
concentrated using Amicon Ultra-15 YM30 centrifugal ﬁlters.
Typical yields were 35−45% of MnIII2-Y· NrdF and 53−63% of
FeIII2-Y· NrdF. Pooled fractions were analyzed for metal
content, Y· content, and activity as described subsequently.
Metal Analysis of NrdF. Mn concentrations were
determined using a Perkin-Elmer Analyst 600 atomic
absorption spectrometer and a standardized Mn solution
from Fluka. Iron concentrations were determined by the
ferrozine assay.33
Y· Determination by EPR Spectroscopy. Spectra were
acquired at 77 K on a Bruker EMX-X band spectrometer using
a liquid N2 ﬁnger dewar. Acquisition parameters for the Mn
III
2-
Y· and FeIII2-Y· cofactors of NrdF were described previously.
34
Spin quantiﬁcation was carried out by comparing the double
integral of the signal intensity to that of a reference sample of E.
coli NrdB (417 μM Y·, 1.2 Y·/β2) as described previously.
34
Activity Assays. Assays were carried out in a ﬁnal volume
of 200 μL containing: 0.5−1 μM MeIII2-Y· NrdF (Me = Fe or
Mn), 1 equiv of NrdE, 3 mM ATP, 1 mM [5-3H]-CDP
(ViTrax, speciﬁc activity ≈ 1100 cpm nmol−1), reductant [8−
20 mM DTT or 40 μM TrxA (8−20 U/mg) or YosR (20−26
U/mg), 0.4 μM TrxB (415 U/mg), and 1 mM NADPH], 50
Figure 2. Separation of holo-MnIII2-Y· NrdF (A) and holo-Fe
III
2-Y·
NrdF (B) from apo-/mis-metalated NrdFs by anion exchange
chromatography on a MonoQ column. The material eluting in the
void volume in (A) is NrdIox. Peak 1 corresponds to apo-/mis-
metalated NrdF and 2 to holo-MeIII2-Y· NrdF.
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mM HEPES, pH 7.6, 15 mM MgCl2, and 1 mM EDTA at 37
°C. The reaction was initiated by addition of [5-3H]-CDP.
Aliquots (35 μL) were removed over 4 min and quenched by
incubation at 100 °C for 2 min. The method of Steeper and
Steuart was used to quantitate dCDP.35 One unit of activity is
the amount of enzyme required to catalyze 1 nmol dCDP
min−1. The eﬀect of the allosteric eﬀectors dATP (0.4 μM to 4
mM) or ATP (50 μM to 4 mM) on activity was carried out as
described above.
The concentration dependence of RNR activity using a 1:1
mixture of α and β was measured with subunit ratios varying
from 0.01−1 μM. At concentrations below 0.1 μM, BSA was
included in the assay solution to a ﬁnal concentration of 0.2
mg/mL. These data were ﬁt to eq 1 with Igor Pro
(Wavemetrics, Lake Oswego, OR).
ν =
+
V
K
[subunit]
[subunit]
max
m (1)
Quaternary Structural Analysis of 1:1 Mixtures of α:β
Using Biophysical Methods. A. Anion Exchange Chroma-
tography. NrdE and MeIII2-Y· NrdF (Me = Fe or Mn, 1 Y·/β2,
∼3.6 Me3+/β2, 1450 U/mg [MnIII2-Y·] or 125 U/mg [FeIII2-
Y·]) were mixed in a 1:1 ratio at 5 μM in 50 mM HEPES, 5%
(w/v) glycerol, pH 7.6 in a total volume of 0.5−1 mL. Samples
were incubated on ice for 20 min and at room temperature for
10 min, followed by centrifugation (20817g, 1 min, 4 °C). All
subsequent steps were at 4 °C. Samples were injected onto a
MonoQ anion exchange column equilibrated in 50 mM Tris,
pH 7.6, 5% (w/v) glycerol and 100 mM NaCl. The column was
washed with 1 CV of the equilibration buﬀer and then
developed with a 160 mL linear gradient from 100 to 500 mM
NaCl in Tris buﬀer at a ﬂow rate of 1 mL min−1 (Supporting
Information, SI-Figure 2). Fractions (2 mL) containing protein
were identiﬁed by A280, pooled, exchanged into storage buﬀer
(50 mM HEPES, pH 7.6, 5% (w/v) glycerol), and concentrated
using an Amicon Ultra-15 YM30 centrifugal ﬁlter. The metal
content, radical content, and activity of the isolated complex
was measured as described above.
B. SEC. Samples of NrdE (3 μM), holo-FeIII2-Y· NrdF (23
μM), holo-MnIII2-Y· NrdF (1 μM), and 1:1 mixtures of α:β (1
μM) in a total volume of 200 μL were centrifuged (20817g, 10
min, 4 °C) and then injected onto a Superdex 200 10/300 GL
column (10 × 300 mm, ∼24 mL) connected to an ÄKTA
Puriﬁer FPLC system (GE Healthcare). Protein was eluted at 4
°C at a ﬂow rate of 0.25 mL min−1 using 50 mM HEPES, pH
7.6, 100 mM NaCl, 15 mM MgCl2, 1 mM EDTA. Molecular
weights were calculated as previously described36 using the
experimentally measured s20,w (subsequent section), the Stokes
radius (Rs) estimated from the SEC retention times, and the
correlation function of Laurent and Killander.37 The column
was calibrated using a High Molecular Weight Gel Filtration kit
(GE Healthcare) containing the following standards: Blue
Dextran 2000 (void volume determination), thyroglobulin (669
kDa, Rs = 85.0 Å), ferritin (440 kDa, Rs = 61.0 Å), aldolase (158
kDa, Rs = 48.1 Å), conalbumin (75 kDa, Rs = 36.4 Å
38), and
ovalbumin (44 kDa, Rs = 30.5 Å).
C. SV-AUC−Experimental Design. Concentration-depend-
ent SV experiments were performed using a Beckman XL-I
analytical ultracentrifuge at the MIT Biophysical Instrumenta-
tion Facility with Fe-β2 (1.2 Y·/β2, 4.0 Fe/β2, 130 U/mg), Mn-
β2 (0.9 Y·/β2, 4.0 Mn/β2, 1545 U/mg), and α. Individual
subunits were analyzed in 50 mM Tris, pH 7.6, 5% (w/v)
glycerol, 150 mM NaCl, 15 mM MgCl2, 1 mM DTT, whereas
1:1 mixtures of α and β were analyzed in 50 mM NaPi, pH 7.6,
150 mM NaCl, 5% (w/v) glycerol, 1 mM TCEP to allow
experiments to be monitored by A230. Protein was exchanged
into buﬀer using three cycles of concentration-dilution with an
Amicon Ultra-15 YM30 centrifugal ﬁlter. The ﬁnal ﬁltrate was
used as the SV reference buﬀer. Samples spanning 0.1−1.5 OD
at A230, A250, or A280 (Supporting Information, SI-Table 3) were
prepared in a total volume of 500 μL by mixing concentrated
protein solution with reference buﬀer to the desired ﬁnal
concentration for each experiment. Epon charcoal double
sector cells (12 mm) assembled with quartz windows were
loaded with ∼440 μL reference solution and ∼430 μL sample
solution, radially calibrated, and thermally equilibrated at 20 °C
for 1.5−2.0 h prior to initiating the experiment. Sedimentation
was measured over 18−19 h with absorption detection at 20 °C
and an angular velocity of 35 000 rpm. Scans were collected
every 1.2 min using ProteomeLab XL-I Graphical User
Interface, version 4.5b (Beckman).39
C.1. Analysis Method. Individual data sets were ﬁt with the
c(s) model implemented in Sedﬁt with a resolution (N) =
200−250, and a regularization factor (P) = 0.95.40,41
Distributions were converted to the standard state (s20,w)
using a solvent density (ρ) = 1.018 g mL−1 (Tris buﬀer) or
1.023 g mL−1 (NaPi buﬀer), solvent viscosity (η) = 1.164 cP
(Tris buﬀer) or 1.170 cP (NaPi buﬀer), and the partial speciﬁc
volume (v)̅ of the species analyzed (Supporting Information,
SI-Table 4); these values were calculated and temperature
corrected with Sednterp.42 All MnIII2-Y· NrdF data sets and the
NrdE and NrdE:FeIII2-Y· NrdF data collected at physiological
concentrations (∼1 μM) were ﬁt with the program Sedphat
using the “hybrid local continuous/global discrete species
model” for a more rigorous determination of s20,w and Mw.
40
The best ﬁt s20,w for each species was used to determine Rs and
the frictional ratio ( f/fo) with Sednterp by turning oﬀ the
temperature corrections, setting ρ = 0.998 g mL−1 and η =
1.002 cP, and calculating the Mw values using the amino acid
sequences of NrdE and NrdF (including the His-tag).
D. Hydrodynamic Modeling. Predictions of the s20,w,
frictional ratio ( f/fo), and Rs for each species were determined
using the program HYDROPRO43 and structural models of
NrdE and NrdF (PDB 4DRO) (Supporting Information, SI-
Table 4).44 A crystallographic structure of B. subtilis NrdE is not
available, and therefore the web-based server PHYRE45 was
used to generate a NrdE model by threading onto the
Salmonella typhimurium NrdE structure (PDB 1PEM, 45%
identity to B. subtilis NrdE; see Supporting Information).46
SDS-PAGE Densitometry. The ratio of α:β in 1:1 mixtures
was estimated by densitometry using standard curves prepared
from known amounts of NrdE and NrdF as described
previously.9 See Supporting Information for details.
■ RESULTS
Puriﬁcation of MeIII2-Y· NrdF (Me = Fe or Mn) to give 1
Y·/β2. The low amounts of Y· and metal content in class Ib β
subunits examined to date suggest that NrdFs (Supporting
Information, SI-Table 1) are heterogeneous mixtures of holo-
and apo-/mismetalated protein. On the basis of the report of
partial separation of Bacillus anthracis holo- and apo-NrdF,24 B.
subtilis NrdF was examined on diﬀerent anion exchange resins
with MonoQ ultimately eﬀecting complete separation of holo-
Fe-β2 and Mn-β2 from apo-/mismetalated-NrdF (Figure 2).
Analysis of pooled peak 2 by atomic absorption and EPR
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spectroscopy revealed 4.1 ± 0.3 Mn/β2 and 1.00 ± 0.09 Y·/β2
for MnIII2-Y· NrdF and by ferrozine assay and EPR spectros-
copy 4.0 ± 0.1 Fe/β2 and 1.05 ± 0.05 Y·/β2 for Fe
III
2Y· NrdF
(Supporting Information, SI-Figure 3). In contrast, pooled
protein from peak 1 (Figure 2) typically had 0.1 Y·/β2, ∼1.0
metal/β2, and no detectable activity. Holo-NrdF from peak 2
has been used in all subsequent experiments.
Puriﬁcation of B. subtilis TrxA, YosR, and TrxB. The
highest activities of class I RNRs have been achieved with
endogenous reducing systems that are distinct for diﬀerent class
Ib RNRs (see Supporting Information, SI-Table 1).25 Mining of
B. subtilis JH624 genome revealed a number of candidate genes.
Thioredoxin (trxA, TR), YosR (yosR, a NrdH or glutaredoxin-
like thioredoxin25,47), and thioredoxin reductase (trxB, TRR)
were ultimately pursued due to homology to the reductants that
maximally supported RNR activity in B. anthracis.9,25 His-
tagged versions of these genes were cloned, overexpressed in E.
coli, and puriﬁed by Ni-aﬃnity chromatography. Each protein
required additional puriﬁcation steps. For TrxA, Sephadex G-75
SEC yielded ≥99% pure protein (Supporting Information, SI-
Figure 1) with a speciﬁc activity of ∼11−20 U/mg using the
DTNB assay in the presence of NADPH and TrxB. For YosR,
Poros HQ/20 FPLC anion exchange chromatography followed
by Sephadex G-75 SEC resulted in ≥95% pure protein
(Supporting Information, SI-Figure 1) with a speciﬁc activity
of ∼20−26 U/mg. Finally, nearly homogeneous TrxB with a
full complement of FAD was obtained with Poros HQ/20
anion exchange (≥95% pure, Supporting Information, SI-
Figure 1) and had a speciﬁc activity of 415 U/mg in the
presence of either TrxA or YosR.
Assay Optimization. Historically, the activity of each
subunit for class Ia RNRs has been assayed independently in
the presence of an excess of the second subunit due to weak
subunit interactions.26,48 Similar assays of Ib RNRs have been
carried out using this protocol.3,5,8,9,24,34,49 Our previous results,
however, suggested the B. subtilis RNR could be assayed as a
holo-enzyme by using equivalent amounts of each subunit.9 To
validate the use of a 1:1 ratio of subunits, experiments were
therefore initially carried out using 0.5−1 μM NrdF, increasing
amounts of NrdE (1, 5, or 10 equiv), 3 mM ATP, and the
endogenous reductants TrxA/TrxB/NADPH. The results with
both Fe- and Mn-loaded NrdF in a 1:1 ratio with NrdE gave
activity very similar to that in the presence of a 5−10-fold
excess of NrdE (data not shown). Thus, all further studies used
a 1:1 ratio of the subunits.
Optimization of Eﬀector (ATP, dATP) Concentrations.
Previous studies of the Fe-loaded S. typhimurium, Lactococcus
lactis, and Mycobacterium tuberculosis class Ib RNRs reported
that dATP strongly stimulated CDP reduction, while ATP had
only a marginal stimulatory aﬀect.3,5,49,50 These results contrast
with the class Ia RNRs, in which dATP stimulates activity by
binding to the speciﬁcity site of α at low concentrations and
inhibits at high concentrations by binding to both the speciﬁcity
and activity site leading to an α4β4 inhibitory complex.
16,18 This
quaternary structure is inaccessible in Ib RNRs as they lack the
ATP cone domain essential for α4β4 formation.
22 Thus, studies
with both ATP and dATP were carried out, and the results are
shown in Figure 3. ATP maximally stimulated CDP reduction
at 1.5−2 mM, while dATP showed maximal stimulation at 8−
10 μM followed by rapid inhibition at higher concentrations.
The eﬀects were similar with Fe-loaded NrdF (data not
shown), although the activity was 5-fold lower. The dATP
behavior was unexpected as there is no ATP cone domain, and
it is distinct from other reported class Ib enzymes.3,5,49,50 The
Mg2+ dependence was also examined and gave an optimum
activity at 10−15 mM, while EDTA had no eﬀect on the
activity (data not shown).
The SA of B. subtilis RNR under optimized conditions with
CDP/(d)ATP is among the highest reported for any member
of this subclass (Table 1; Supporting Information, SI-Table 1).
Holo-MnIII2-Y· and Fe
III
2-Y· NrdF gave, respectively, 1475 ±
129 and 125 ± 23 U/mg with TrxA and 997 ± 9 U/mg and
106 ± 8 U/mg with YosR (Table 1). Given that we believe
both cluster loading and reductant identity are important
contributors to RNR activity, we compared the activities of
puriﬁed and unpuriﬁed MeIII2-Y· NrdF using both DTT and
TrxA/TrxB/NADPH to establish the relative contributions of
each factor to the overall activity enhancement observed with B.
subtilis RNR. Surprisingly, the use of the endogenous reducing
Figure 3. Eﬀector nucleotide concentration-dependence of CDP
reduction by a 1:1 mixture of MnIII2-Y· NrdF and NrdE. Assays were
conducted with 0.5 μM of each subunit. Error bars represent ±1
standard deviation from the mean. (A) Dependence of B. subtilis RNR
activity on ATP. (B) Dependence of B. subtilis RNR activity on dATP.
Table 1. Optimized CDP Reduction Activity of B. subtilis
NrdFa
Me reductantb eﬀector SA (U/mg)
Fe DTT 3 mM ATP 52 ± 3
1 mM ATP 22c
TrxA 3 mM ATP 125 ± 23
86 ± 5d
YosR 3 mM ATP 106 ± 8
TrxA 4 μM dATP 172 ± 22
Mn DTT 3 mM ATP 146 ± 14
1 mM ATP 160c
TrxA 3 mM ATP 1475 ± 129
721 ± 128e
YosR 3 mM ATP 997 ± 9
TrxA 7 μM dATP 1257 ± 128
aPuriﬁed MeIII2-Y· NrdF characteristics: Fe-β2 = 1.1 Y·/β2, 3.6 Fe/β2;
Mn-β2 = 1.0 Y·/β2, 3.2 Mn/β2.
bDTT, ﬁnal concentration 20 mM.
TrxA or YosR, the ﬁnal concentration 40 μM and assays included 0.4
μM TrxB and 1 mM NADPH. cPrevious study.9 dUnpuriﬁed FeIII2-Y·
NrdF (0.5 Y·/β2, 2.8 Fe/β2).
eUnpuriﬁed MnIII2-Y· NrdF (0.6 Y·/β2,
2.6 Mn/β2).
Biochemistry Article
dx.doi.org/10.1021/bi401056e | Biochemistry 2014, 53, 766−776770
system had a much greater eﬀect on activity (5−10-fold
enhancement with MnIII2-Y·) than did cluster assembly (0−2-
fold enhancement, Table 1). This starkly contrasts with the B.
anthracis RNR, where similar activities were observed with
DTT and Trx1.25
Reconstitution of Active RNR from Recombinant NrdE
and Reconstituted NrdF. The most distinct aspect of the
copuriﬁcation of endogenous NrdE and NrdF was that the
complex was maintained in the absence of substrates, eﬀectors,
and Mg2+.9 Analysis of a 1:1 mixture NrdE:NrdF (5 μM) on a
MonoQ FPLC column reproduced this result (Supporting
Information, SI-Figure 2). A single peak eluted between 380−
410 mM NaCl, behavior distinct from NrdE alone (two peaks
that eluted between 265−300 mM NaCl and 325−340 mM
NaCl) and reconstituted NrdF (two peaks that eluted in the
range of 250−280 mM NaCl and 280−310 mM NaCl) using
the same NaCl gradient. SDS-PAGE densitometry analysis of
the fractions showed a 1:1 subunit ratio (Supporting
Information, SI-Figure 4). Both the recovered Fe- and Mn-
loaded complexes were active in CDP reduction (116 ± 5 U/
mg and 889 ± 6 U/mg, respectively) and contained a nearly full
complement of metal (Fe/β2 = 3.8 ± 0.2; Mn/β2 = 3.8 ± 1.6)
and Y· (Fe-β2 = 1.2 Y·/β2, Mn-β2 = 0.7 Y·/β2).
Km for α/β Interaction. Recent Western blot analysis of
wild type B. subtilis JH624 using antibodies to NrdE and NrdF
revealed that the two proteins were present in the crude cell
extracts in a 1:1 subunit ratio at ∼1 μM.9 Thus, CDP reductase
activity using a 1:1 subunit ratio was examined with subunit
concentrations that ranged from 0.01 μM to 1 μM in the
presence of ATP (3 mM) and TrxA/TrxB/NADPH. The
results are shown in Figure 4. Fitting the data to eq 1 gave Vmax
= 124 ± 6 U/mg and Km = 0.06 ± 0.01 μM for Fe-β2 and Vmax
= 1081 ± 36 U/mg and Km = 0.025 ± 0.003 μM for Mn-β2.
The apparent aﬃnity between the subunits is ∼10× greater
than for the class Ia RNRs and the B. anthracis class Ib
RNR.13,23,24
Quaternary Structure by SEC. SEC was used initially to
estimate the molecular weights of the subunits and quaternary
structure(s) of holo-RNR. When run at physiological
concentrations (∼1 μM), NrdF (Fe- or Mn-loaded) eluted
predominantly as a single peak (Figure 5A) with a molecular
weight of 80.1 kDa (Table 2), consistent with a dimer. A small
amount of monomer was also observed (49.6 kDa, Table 2).
NrdE also eluted as a single peak (Figure 5A) with a molecular
weight of 82.7 kDa (Table 2), consistent with a monomer. The
results with holo-RNR are shown in Figure 5B. The
chromatogram reveals a series of broad peaks with retention
times ranging from 37−60 min, indicating the presence of
interconverting species. Regardless of the metal loading, the
highest percentage of protein eluted at Ve = 47 min,
corresponding to a molecular weight of 204.6 kDa (Table 2),
suggesting, in conjunction with the other hydrodynamic
properties, the presence of an α2β2-like complex with a
structure similar to the elongated S. typhimurium class Ib
holo-RNR (Table 2).51 However, these results clearly indicate
that the quaternary structure(s) of the B. subtilis class Ib RNR
are not stable in the absence of substrate or eﬀector
nucleotides, resulting in an ensemble of diﬀerent interconvert-
ing species, despite the low experimentally measured Km
(Figure 4).
Quaternary Structure by SV-AUC. SV experiments with
each subunit and with a 1:1 mixture of subunits were carried
out at diﬀerent concentrations (Supporting Information, SI-
Table 3) to gain further insight into their quaternary states. To
aid in the analysis of our experimental data, HYDROPRO43 was
used to predict hydrodynamic properties for NrdF and NrdE
Figure 4. Subunit concentration dependence of activity of a 1:1
mixture of NrdE:FeIII2-Y· NrdF (A), or NrdE:Mn
III
2-Y· NrdF (B).
Assay conditions include 1 mM CDP, 3 mM ATP, and optimized
concentrations of TrxA/TrxB/NADPH. Error bars represent ±1
standard deviation from the mean. Blue lines are the ﬁts of the data to
eq 1, yielding (A) Vmax =124 ± 6 nmol min
−1 mg−1 and Km = 0.062 ±
0.012 μM dATP, and (B) Vmax = 1081 ± 36 nmol min
−1 mg−1 and Km
= 0.025 ± 0.003 μM dATP.
Figure 5. Biophysical characterization of the B. subtilis class Ib RNR
(all at 1 μM) in the absence of nucleotides. (A) Overlaid SEC
chromatograms of holo-MnIII2-Y· NrdF (red trace) and NrdE (blue
trace). (B) SEC chromatogram of a 1:1 mixture of MnIII2-Y·
NrdF:NrdE. Letters above the chromatograms indicate the retention
time of molecular weight standards (d = Blue dextran 2000, t =
thyroglobulin, f = ferritin, a = aldolase, c = conalbumin, o =
ovalbumin). (C) Overlaid s20,w distributions of holo-Mn
III
2-Y· NrdF
(red trace) and NrdE (blue trace). (D) The s20,w distribution of a 1:1
mixture of FeIII2-Y· NrdF:NrdE. (E) A plot of the weight averaged
frictional ratios versus loading concentration of 1:1 mixture of FeIII2-Y·
NrdF:NrdE shows a steep decrease as the subunit concentrations
increase.40 (F) An isotherm plotting the weight averaged s20,w against
loading concentration of 1:1 mixtures of FeIII2-Y· NrdF:NrdE indicates
complicated quaternary structural dynamics of the B. subtilis class Ib
RNR.
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from the NrdF crystal structure (PDB 4DRO)44 and a
threading model of NrdE using the S. typhimurium NrdE
structure (PDB 1PEM).46 Predictions were also made for
docking models of the B. subtilis α2β2 complex prepared by in
silico alignment of the subunit models with the E. coli class Ia
RNR globular docking model and the elongated X-ray structure
of the S. typhimurium class Ib holo-RNR.51,52 The results of the
HYDROPRO calculations are summarized in Supporting
Information, SI-Table 4.
The sedimentation behavior of MnIII2-Y· NrdF (1−11 μM),
NrdE (1−30 μM), and NrdE:FeIII2-Y· NrdF (25 nM to 7 μM)
were determined and analyzed using the c(s) model in Sedﬁt
and, due to the detection by the c(s) ﬁts of interactions
occurring on the time scale of sedimentation, with Sedphat.
The details of these analyses are presented in the Supporting
Information and in SI-Figures 5−7. The results for 1 μM
MnIII2-Y· NrdF are shown in Figure 5C and reveal two peaks
representing stable, noninteracting entities at all concentrations
examined (Supporting Information, SI-Figure 5). Globally
ﬁtting the data sets in Sedphat yielded s20,w = 3.64 and 4.72 S
for each entity, along with the corresponding Mw’s listed in
Table 2. These results, in comparison with HYDROPRO
predictions (Supporting Information, SI-Table 4) and SEC
results (Table 2), suggest that the predominant species is a
dimer and the minor species is a monomer. These results are
consistent with the general reports that all class I small subunits
are dimers.
The results of similar experiments with NrdE are shown in
Figure 5C and Supporting Information, SI-Figure 6. At 1 μM
NrdE, a single peak with an s20,w = 5.56 S is observed. However,
analysis of increasing protein concentrations to 9 μM reveal a
second peak at s20,w = 7.40 S (Supporting Information, SI-
Figure 6A) and at still higher concentrations (30 μM), larger
oligomeric states (Supporting Information, SI-Figure 6B).
Thus, NrdE is in a regime where the protein is not stable
and aggregates on the time scale of our experiments. The NrdE
data analyzed in Sedphat, when compared to the HYDROPRO
predictions (Supporting Information, SI-Table 4) and our SEC
data (Table 2), suggest that the peak at low concentrations is
the NrdE monomer. As the protein concentration increases
NrdE appears to form a dimer that is unstable and continues to
aggregate (Supporting Information, SI-Figure 6). We note that
α, in prokaryotic and eukaryotic class Ia RNRs, in general
exhibits low solubility and that aggregation has been reported
by SAXS and EM analyses.16 However, ours is the ﬁrst
systematic report of the complexity of α aggregation.
The analysis of a 1:1 mixture NrdE:FeIII2-Y· NrdF using c(s)
is shown in Figure 5D (also see Supporting Information, SI-
Figure 7). Even at 1 μM, dynamic behavior of the subunits is
indicated by the reaction boundary that has apparent peaks at
4.38 and 9.66 S. A plot of the best ﬁt f/fo from the c(s) models
versus loading concentration (Figure 5E) reveals a sharp
decrease as the protein concentration increases. As described in
more detail in the Supporting Information, this observation
indicates the presence of interconverting species. The data were
imported into Sedphat, and the peaks were treated as discrete
species with individual f/fo.
40 The calculated hydrodynamic
properties of the smaller species (s20,w = 3.64 S) are consistent
with a NrdF monomer. For the larger species (s20,w = 9.59 S),
the analysis suggests the presence of oligomeric structures that
are similar to, but smaller than, that predicted for an α2β2
complex (Supporting Information, SI-Table 4). As noted
however, this is clearly not a discrete species as this peak shifts
to larger s20,w, and larger complex(es) of unknown composition
become evident as the protein concentration increases (Figure
5F, Supporting Information, SI-Figure 7). Thus, we currently
do not have a model for the behavior of the 1:1 NrdE:NrdF
complex. Further analysis requires the presence of diﬀerent
substrate and eﬀector pairs after their binding stoichiometries
are established and requires development of a method to
speciﬁcally reduce the Y· in NrdF to prevent chemistry during
the analysis.34
■ DISCUSSION
In 2010, it was shown that class Ib RNRs can assembly a MnIII2-
Y· cofactor with the aid of the unusual ﬂavodoxin NrdI and O2
in vitro34 and that enzymes isolated from three endogenous
sources have a similar cluster.6,7,9 More recently, in vitro
assembly of a MnIII2-Y· cofactor using species speciﬁc NrdIs
have been carried out in B. subtilis,9,27 Streptococcus sanguinis,53
B. anthracis, and B. cereus24 with similar results. The interesting
observation that a FeIII2-Y· cofactor can self-assemble in these
enzymes in vitro and maintain catalytic activity, although
demonstrably lower than the Mn-loaded cofactor (Supporting
Information, SI-Table 1),3−5,46,51 raises important biological
questions as to the nature of the active cofactor in vivo and
whether it changes with the growth conditions of the organism.
Given that many pathogenic organisms 54 require a class Ib
RNR for aerobic growth and that humans use a FeIII2-Y· class Ia
RNR, the distinctions in the mechanisms of cofactor biosyn-
thesis, allosteric regulation, and quaternary structure oﬀer new
opportunities for therapeutic intervention. Thus, understanding
Table 2. Biophysical Characteristics of B. subtilis Class Ib RNR in the Absence of Eﬀectorsa
NrdE (1 μM) MnIII2-Y· NrdF (1 μM) 1:1 NrdE:Fe
III
2-Y· NrdF (1 μM)
sample meas pred meas pred meas pred meas pred meas pred
Mw (kDa) 71.4 83.0 35.4 40.6 94.2 81.3 30.8 40.6 199.2 247.2
82.7 49.6 80.1 204.6
s20,w (S) 5.56 5.37 3.64 3.47 4.72 5.51 3.64 3.47 9.59 10.8
b
11.4c
f/fo 1.23 1.27 1.15 1.20 1.40 1.20 1.15 1.20 1.46 1.30
b
1.22 1.40 1.38 1.21 1.23c
Rs (Å) 35.4 36.4 26.1 27.2 40.1 34.6 26.1 27.2 60.9 54.0
b
35.3 31.9 39.6 50.4 51.2c
state(s) α β β2 β αn(β2)m
aValues derived from ﬁts of the SV-AUC in Sedphat (regular font) and from the SEC data (italicized font) using the s20,w values determined by AUC.
bPredicted values from HYDROPRO based on alignment of the B. subtilis class Ib RNR with the S. typhimurium class Ib holo-RNR.51 cPredicted
values from HYDROPRO based on alignment of the B. subtilis class Ib RNR with the E. coli class Ia docking model.52
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the basic properties of the Ib RNRs, as well as their similarities
and diﬀerences to one another and to class Ia RNRs, is an
important ﬁrst step.
Recent studies on the class Ib RNRs (with the MnIII2-Y·
NrdF) from B. anthracis and B. cereus have identiﬁed and
characterized the endogenous reductants required to make
deoxynucleotides at optimum rates.24,25 Despite this important
contribution, however, these and other class Ib RNRs
(Supporting Information, SI-Table 1) still have low catalytic
activity. The B. anthracis MnIII2-Y· NrdF assembled with NrdI
gave 0.3−0.4 Y·/β2, but the reported activity was only 44−70
U/mg.24,25 Similar activities were observed using DTT (40−63
U/mg) alone or with either TR or NrdH.24,25 The B. anthracis
FeIII2-Y· NrdF with 0.6 Y·/β2 was reported to have activity of
only 8 U/mg.24 This value is very low given the high Y·
content, which in the case of the Ia RNRs, is correlated with
activity.55 Our initial report on the activity of endogenous B.
subtilis RNR using DTT as reductant was also low, 160 U/mg.
To study the class Ib RNRs, we thus felt that we needed to
better understand the basis for the low catalytic activity, which
we believed to lie with cluster assembly in NrdF and the
reductant used to support NDP reduction. Our studies show
that apo-/mismetalated forms of NrdF can be separated from
holo-protein, yielding MnIII2-Y· NrdF with 1 Y·/β2 and 4 Mn/
β2. Contrary to our expectations, the purity of Me
III
2-Y· NrdF
was only a minor factor in activity enhancement (Table 2).
Rather, the identity of the reductant used to support turnover
was the major limiting factor in obtaining highly active RNR
from B. subtilis.9 The optimum endogenous reducing system
was TR/TRR/NADPH, which supported catalytic activity of
∼1450 U/mg. However, the major contributor to high
enzymatic activity may vary from species to species, given
that with B. anthracis, Trx1 and DTT yielded similar activities
using poorly loaded MnIII2-NrdF.
25 The basis for the low
activity in the B. anthracis system is likely associated with
mismetalated NrdFs which interfere with formation of an active
RNR complex.
The availability of highly active B. subtilis NrdF and NrdE
have allowed us to assemble an active RNR with a 1:1 ratio of
subunits and to analyze the resulting activity in physiological
concentration ranges (Figure 4). The Km of 0.025 μM contrasts
with values of ∼0.2 μM measured for the Ia RNR subunits, in
which each subunit is assayed independently in the presence of
a 5−10-fold excess of the second subunit to generate the
“active” complex.13,14 All the assays on the B. anthracis RNR
were carried out using the class Ia method.24,25 These
conditions could alter quaternary structures (α and α/β
structures) and result in inhibition under these assay conditions
(see discussion below). With bacterial systems, we now believe
that all assays of enzymatic activity should be carried out with a
1:1 ratio of the two subunits, accompanied by a study to
establish the optimum concentration range for maximum active
complex formation with each RNR.
Two issues warrant further discussion of our results with B.
subtilis in comparison those with B. anthracis (and B. cereus) Ib
RNRs: the nature of the endogenous reductant(s)24,25 and the
nature and dynamics of their quaternary structure(s). In the
studies of Gustafsson et al., interrogation of the B. anthracis
genome identiﬁed three thioredoxins, two potential thioredoxin
reductases, and three potential glutaredoxin-like proteins all of
which were cloned, expressed, and screened for their ability to
support RNR activity.25 The turnover numbers for the B.
anthracis RNR were highest with Trx1/TR1 and 7-fold greater
than with NrdH/TR1 (Supporting Information, SI-Table 1).
Furthermore, under their growth conditions, Western analysis
revealed that Trx1 was the predominant RNR reductant in the
cell.25
We used the B. anthracis genes25 as queries of the B. subtilis
genome and identiﬁed six thioredoxin-like proteins (TrxA,
Ydbp, YtpP, YdfQ, YusE, and YusI), one thioredoxin reductase
(TrxB), and two glutaredoxin-like proteins (YosR and BdbA).
TrxA and TrxB are homologues of B. anthracis Trx1 (75%
identity) and TR1 (87% identity), suggesting they likely
function as the reducing system for the B. subtilis RNR. In
addition, previous gene knock-out experiments of all of these
proteins and the growth of the resulting deletion mutants in
rich or minimal medium revealed that only TrxA and TrxB are
essential.10,56 Using these puriﬁed proteins, we established that
endogenous reductants eﬀect a ∼10-fold increase on RNR
activity relative to DTT (Table 1) in contrast with the B.
anthracis RNR.25 We also note that we have observed a 20-fold
diﬀerence between endogenous reductant and DTT with the S.
sanguinis class Ib RNR.53
It was pointed out previously that B. subtilis has a second
class Ib RNR, located in the bnrdEFI operon, which could
potentially be physiologically important.24 The gene yosR,
recently reannotated as nrdH, is adjacent to this operon,25,54
prompting us to examine this protein in our assays as well. As
was observed with the B. anthracis RNR, YosR(NrdH) exhibits
activity similar to TrxA in ribonucleotide reduction (Table 1).
In B anthracis, as noted above, Western analysis suggested that
TrxA was the endogenous reductant. Previous studies in B.
subtilis have established that the bnrdEFI operon is dispensable
for its survival under numerous growth conditions,11,12,57
supported by transcriptional analysis under rich and minimal
growth conditions in which both yosR and bnrdEFI were
expressed at very low levels.58 Thus, TrxA is most likely the
physiological reductant in B. subtilis as well.
The most interesting observation from our studies is
associated with our analysis of quaternary structure. We
expected tight subunit association in the absence of nucleotides
(dNTPs), based on our isolation of endogenous B. subtilis
RNR9 and the concentration dependence of activity (Figure 4),
in contrast to the class Ia RNRs (Kd of 0.4 μM).
14,59 Our
studies using SEC and SV-AUC, however, revealed that this is
not the case (Figure 5). Under physiological concentrations (1
μM) with no nucleotides, both methods revealed mixtures of
subunits and complexes of subunits. GEMMA analysis of the B.
anthracis class Ib RNR in the absence of nucleotides also
revealed mixtures of subunits and an α2β2 complex.
24 In neither
our case, nor in the case of these earlier studies, however has a
study of aﬃnities and the rates for subunit association and
dissociation been carried out.
Finally, the observation of potent inhibition of RNR activity
by dATP given the absence of an ATP cone domain deserves
comment. The results are distinct from all class Ib RNRs
reported to date, which show no inhibition even at
concentrations of 1 mM dATP.5,49,50,53,60 Furthermore, with
dATP and the B. anthracis RNR, the GEMMA analysis revealed
individual subunits, αβ2, and α2β2, but no large quaternary
states were reported.24 Thus, the cause for the potent inhibition
with the B. subtilis RNR requires further study.
Our studies16,17,22 suggest that the paradigm of RNR as α2β2
in the literature needs to be re-examined. The diﬃculties
associated with obtaining structures of prokaryotic RNRs with
both subunits present are likely associated with the dynamics of
Biochemistry Article
dx.doi.org/10.1021/bi401056e | Biochemistry 2014, 53, 766−776773
their interactions. Undoubtedly these dynamics will be aﬀected
by the presence of ATP, dNTPs, and Mg2+, and studies of these
eﬀects under physiologically relevant conditions are currently in
progress. In order to carry out these types of studies, highly
active protein with fully loaded metallo-cofactor is essential, and
our studies reported herein present the foundation to
investigate quaternary structure and its connection to the
enzymatic activity and allosteric regulation of RNRs.
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NrdH-Redoxin Protein Mediates High Enzyme Activity in Manganese-
reconstituted Ribonucleotide Reductase from Bacillus anthracis. J. Biol.
Chem. 286, 33053−33060.
(25) Gustafsson, T. N., Sahlin, M., Lu, J., Sjöberg, B. M., and
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